In the webinar “Is it a Blast or a Lymphocyte,” Dr. Nagendra will present multiple case studies featuring CBC data and morphologic cell images. Through an interactive format, participants will attempt to identify the cell type, followed by Dr. Nagendra’s expert approach to classification.
When Hurricane Helene made landfall, it left a trail of devastation in western North Carolina and eastern Tennessee, but it also revealed the strength and resilience of communities in the area.
CASSS Bioassays 2025 -- Developing precise, accurate and reproducible cell-based potency assays in a GMP environment presents multiple challenges. Potency assay are laborious to set up, requiring on average 2-4 hours of hands-on time (HoT) for a less complex assay with many analysts reporting repetitive motion issues.
Latent autoimmune diabetes in adults (LADA) is characterized by a slower progression of autoimmune beta-cell destruction compared to classic Type 1 diabetes (T1D), often leading to its misclassification as Type 2 diabetes (T2D) at initial presentation.
We offer Toxicology solutions to propel your development program including general tox, genetox, DART, Immunotox, ocular, inhalation and surgical solutions and more.
AACR 2025 -- Antibody-drug conjugates (ADCs) represent a significant advancement in cancer treatment by combining the targeting ability of monoclonal antibodies with cytotoxic drugs.
Two-dimensional (2D) cell cultures have been extensively used as tools to predict preclinical outcomes before proceeding to expensive animal studies despite their limited success in replicating in vivo studies.
Model growth kinetics and response to multiple treatment types were evaluated for syngeneic Renca murine renal cell carcinoma. Immune profile characterization was performed via flow cytometry to assess changes within the immune cell subsets following different treatment types and from control tumors at different tumor volumes.
